Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioCardia, Inc. Director's Dealing 2016

Oct 26, 2016

35081_dirs_2016-10-26_36c8362c-40f8-4765-b518-0e6e034f73c5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BioCardia, Inc. (BCDA)
CIK: 0000925741
Period of Report: 2016-10-24

Reporting Person: STERTZER SIMON H (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 30956710 Indirect
Common Stock 1258925 Indirect
Common Stock 5386743 Indirect
Common Stock 4716171 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Director stock option (right to buy) $0.1300 2020-11-11 Common Stock (162941) Direct
Director stock option (right to buy) $0.1300 2020-12-23 Common Stock (54307) Direct
Director stock option (right to buy) $0.1500 2023-07-09 Common Stock (678996) Direct

Footnotes

F1: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees.

F2: These shares are held by the Stertzer Gamma Trust, of which the Reporting Person is the grantor.

F3: These shares are held by Stertzer Holdings LLC, and the Reporting Person may be deemed to have beneficial ownership of such shares.

F4: These shares are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are sole members and managers.

F5: The shares subject to the option are fully vested and immediately exercisable.

F6: One-forty-eighth of the shares subject to the option vest on August 1, 2013 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.